Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies”
- Yuan Pin Hsu
- , Chin Wang Hsu
- , Chiehfeng Chen
- Taipei Municipal Wanfang Hospital
- Department of Emergency
- TMU Research Center of Cell Therapy and Regeneration Medicine
- School of Public Health
- Master Program in Applied Epidemiology
- Master Program in Long-term Care
- Master Program in Global Health and Health Security
- School of Biomedical Engineering
- Ph.D. Program in Global Health and Health Security
Research output: Contribution to journal › Letter › peer-review